| Name | PF-06454589 |
|---|---|
| Synonyms |
5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidine
4-[5-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine PF-06454589, 10 mM in DMSO 7H-Pyrrolo[2,3-d]pyrimidine, 5-(1-methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl) PF-06454589 ;PF 06454589 ;PF06454589 Inhibitor,G2019S RK2,inhibit,RK2,pkinson's disease,PF06454589,PF 06454589,PF-06454589,Leucine-rich reat kinase 2 5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine |
| Description | PF-06454589 is a potent and selective LRRK2 inhibitor. |
|---|
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 582.0±50.0 °C at 760 mmHg |
| Molecular Formula | C14H16N6O |
| Molecular Weight | 284.316 |
| Flash Point | 305.8±30.1 °C |
| Exact Mass | 284.138550 |
| LogP | 0.08 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.760 |